Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | Clinrol

Log in Book a demo

The AI-native operating system for clinical trials.

The OS for Clinical Trials

Products

Clinrol Connect
Clinrol Recruit
Clinrol Engage

Solutions

Sponsors
Research sites
Patients
Healthcare providers

Company

About
Blogs
Careers
Contact

Trust & status

Trust centre
System status

Conditions

Breast cancer
Obesity
Hyperemesis gravidarum
Lung cancer
Lupus
Multiple sclerosis
Type 2 diabetes
COVID-19
Traumatic brain injury (TBI)
Asthma
Prostate cancer
Stroke
ADHD
Alzheimer's disease
Pain
Gut conditions
Other cancers
Parkinson's disease
Depression
Cardiovascular disease
View all conditions

© 2026 Clinrol. All rights reserved.

Privacy Terms of service Cookie policy

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | Clinrol